HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China flag China · Delayed Price · Currency is CNY
3.430
+0.070 (2.08%)
Feb 3, 2026, 3:04 PM CST

SHE:002437 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
439.23481.96711.281,2381,496895.45
Trading Asset Securities
390.8230-50.56--
Cash & Short-Term Investments
830.04511.96711.281,2881,496895.45
Cash Growth
77.09%-28.02%-44.79%-13.87%67.04%-31.74%
Accounts Receivable
113.8128.62207.67236.82235.59339.56
Other Receivables
25.8418.8726.6536.5382.85108.92
Receivables
139.64147.49234.32273.35318.45448.47
Inventory
152.93188.67190.67214.14352.09370.96
Other Current Assets
26.4229.0618.1940.434.1770.23
Total Current Assets
1,149877.191,1541,8162,2001,785
Property, Plant & Equipment
993.891,0291,0591,1191,2351,340
Long-Term Investments
278.91277.56298.23458.25498.33555.08
Goodwill
369.03369.03369.03369.03411.16411.16
Other Intangible Assets
171.48166.66191.3221.18290.34350.1
Long-Term Deferred Tax Assets
15.3916.4621.0133.7724.1929.95
Long-Term Deferred Charges
15.7314.458.239.717.2129.19
Other Long-Term Assets
36.4874.7351.5846.6218.2116.01
Total Assets
3,0302,8253,1524,0744,6954,516
Accounts Payable
56.7360.4569.8875.48270.49284.36
Accrued Expenses
47.786.51109.41516.94527.16624.1
Short-Term Debt
70.04-675.691,4551,5581,352
Current Portion of Leases
1.371.33----
Current Income Taxes Payable
41.0610.239.6710.269.334.94
Current Unearned Revenue
26.3344.250.0383.1786.9859.02
Other Current Liabilities
582.55620.33496.47195.49226.24215.63
Total Current Liabilities
825.78823.031,4112,3362,6782,541
Long-Term Leases
0.991.95----
Long-Term Unearned Revenue
12.5412.9217.8721.4324.5328.32
Long-Term Deferred Tax Liabilities
11.7913.2812.1212.8712.5513.73
Other Long-Term Liabilities
1.081.081.080.030.820.83
Total Liabilities
852.18852.261,4422,3712,7162,583
Common Stock
2,2462,2802,1982,1982,1982,198
Additional Paid-In Capital
417.03456.81380.47471.13448.21445.2
Retained Earnings
-436.98-680.75-913.51-1,034-742.51-530.39
Treasury Stock
-64.97-102.03----
Comprehensive Income & Other
-3.73-3.09-3.32-4.17-9.61-266.71
Total Common Equity
2,1571,9511,6621,6311,8941,846
Minority Interest
20.6422.1548.4672.384.786.71
Shareholders' Equity
2,1781,9731,7101,7041,9791,933
Total Liabilities & Equity
3,0302,8253,1524,0744,6954,516
Total Debt
72.393.28675.691,4551,5581,352
Net Cash (Debt)
757.65508.6835.59-166.67-62.42-457
Net Cash Growth
80.18%1329.47%----
Net Cash Per Share
0.330.220.02-0.08-0.03-0.21
Filing Date Shares Outstanding
2,2462,2802,1982,1982,1982,198
Total Common Shares Outstanding
2,2462,2802,1982,1982,1982,198
Working Capital
323.2654.16-256.7-520.11-477.9-755.39
Book Value Per Share
0.960.860.760.740.860.84
Tangible Book Value
1,6171,4151,1011,0411,1931,085
Tangible Book Value Per Share
0.720.620.500.470.540.49
Buildings
-1,2331,2321,2391,3101,338
Machinery
-797.43807.63803.46801.97840.86
Construction In Progress
-1.893.0512.891.85.95
Source: S&P Global Market Intelligence. Standard template. Financial Sources.